BLCO Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—Forward 14.73
EPS (TTM)$-0.62-88.6% YoY
Profit margin-7.1%HEALTHCARE
Market cap$5.82BMid cap
Wall Street coverage
$18.04median target· current $14.44 (+24.9%)14 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 14.73
- PEG ratio
- 0.89
- P/B
- 0.91
- P/S (TTM)
- 1.14
- EV/EBITDA
- 16.50
Profitability & growth
- ROE (TTM)
- -5.4%
- Operating margin
- 11.3%
- Revenue growth YoY
- 9.8%
- Dividend yield
- —
- Beta
- 0.65
Last earnings
Mar 31, 2026 · Estimate $0.05 · Reported $0.08
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Bausch + Lomb Corp
Company profileBausch Lomb Corporation is an eye health company in Canada and internationally. The company is headquartered in Vaughan, Canada.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 520 APPLEWOOD CRESCENT, VAUGHAN, ON
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$5.82B
Shares outstanding$356.5M
52W high$18.91
52W low$10.83
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
B
Agent
The AI built for clarity
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer
B
Agent